Tisotumab vedotin versus investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG 3057, trial in progress).

Ignace  Vergote

Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Mersana; MSD; Novocure; Octimet (Inst); Oncoinvent; Roche; Sotio; Tesaro (Inst); Verastem (Inst); Zentalis

Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)

Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro

Bradley J.  Monk

Leadership - US Oncology

Honoraria - Abbvie; Advaxis; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Asymmetric Therapeutics; Boston Biomedical; ChemoID; Clovis Oncology; Deciphera; Eisai; Elevar Therapeutics; Geistlich Pharma; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Immunomedics; Incyte; Iovance Biotherapeutics; Iovance Biotherapeutics; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Nucana; Oncomed; Oncoquest; Oncosec; Perthera; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Senti Biosciences; Starton Therapeutics; Takeda; Tarveda Therapeutics; TESARO/GSK; Vascular Biogenics; Vavotar Life Sciences; Vigeo Therapeutics

Consulting or Advisory Role - Abbvie; Advaxis; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Asymmetric Therapeutics; Boston Biomedical; ChemoCare; Chemocare; ChemoID; Clovis Oncology; Deciphera; Eisai; Geistlich Pharma; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Immunomedics; Incyte; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Nucana; Oncomed; Oncoquest; Oncosec; Perthera; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Senti Biosciences; Sorrento Therapeutics; Sorrento Therapeutics; Takeda; Tarveda Therapeutics; TESARO/GSK; Vascular Biogenics; Vavotar Life Sciences; Vigeo Therapeutics

Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK

Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)

Robert L.  Coleman

Employment - US Oncology

Stock and Other Ownership Interests  - McKesson

Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro

Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech

Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group

Leslie M.  Randall

Honoraria - BluPrint Oncology; Curio Science; PER; Projects in Knowledge; Projects in Knowledge

Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; EMD Serono; Genentech/Roche; GOG Foundation; Merck; Mersana; Myriad Genetics; Novocure; Rubius Therapeutics

Speakers' Bureau - AstraZeneca; Merck; Tesaro

Research Funding - Aivita Biomedical (Inst); Akeso Biopharma (Inst); AstraZeneca (Inst); GEICO (Inst); Genentech/Roche (Inst); Merck (Inst); On Target Laboratories (Inst); Pfizer (Inst); Tesaro (Inst)

Keiichi  Fujiwara

Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Zeria Pharmaceutical

Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; Genmab; MSD; Pfizer; Taiho Pharmaceutical; Takeda

Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Regeneron (Inst); Shionogi (Inst); Zeria Pharmaceutical (Inst)

Travel, Accommodations, Expenses - Abbvie; MSD; Pfizer

Christian  Marth

Honoraria - AstraZeneca; GlaxoSmithKline; Pfizer; Roche

Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Pfizer; Roche

Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche

Linn Lena  Woelber

Honoraria - GlaxoSmithKline; Medac; MSD Oncology; Pfizer; promedicis; Roche; Tesaro; Teva

Consulting or Advisory Role - Genmab; Roche Molecular Diagnostics; Tesaro

Research Funding - Medac (Inst); Roche Molecular Diagnostics (Inst)

Travel, Accommodations, Expenses - Medac; Tesaro

Els  Van Nieuwenhuysen

No Relationships to Disclose

David  Cibula

No Relationships to Disclose

Paula  Calvert

Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Novartis; Pfizer; Takeda

Ingrid  Boere

Research Funding - Seagen

Antonio  González-Martín

Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; GlaxoSmithKline; Mersana; Roche

Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche

Research Funding - GlaxoSmithKline; Roche

Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche

Elsa  Kalbacher

Honoraria - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK

Consulting or Advisory Role - AstraZeneca; Roche; Tesaro/GSK

Travel, Accommodations, Expenses - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK

Nicoletta  Colombo

Honoraria - Amgen; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; mersana; MSD Oncology; Novartis; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro

Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; MSD Oncology; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro

Domenica  Lorusso

Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck Serono; MSD

Consulting or Advisory Role - PharmaMar

Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD

Research Funding - Clovis Oncology (Inst); GlaxoSmithKline (Inst); MSD (Inst); PharmaMar (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; GlaxoSmithKline; PharmaMar; Roche

Susana N.  Banerjee

Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Pfizer

Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Carrick Therapeutics (Inst); Clovis Oncology; GenMab; GlaxoSmithKline; Merck; Mersana; MSD Oncology; Roche; Tesaro

Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Nucana

Fernando C.  Maluf

Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech

Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)

Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme

Ibrahima  Soumaoro

Employment - Genmab

Stock and Other Ownership Interests  - Bristol-Myers Squibb; Genmab

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genmab

Brian M.  Slomovitz

Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Merck; Myriad Genetics